LONG TERM COSTS AND OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS NOT RESPONDING TO CONVENTIONAL THERAPY TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS: THE EXTENSION OF PSORIATIC ARTHRITIS COST EVALUATION (PACE) STUDY

被引：1
|
作者：
Cortesi, P. A. [1 ]
Olivieri, I [2 ,3 ,4 ,5 ]
de Portu, S. [6 ]
Salvarani, C. [7 ]
Cauli, A. [8 ]
Lubrano, E. [9 ]
Spadaro, A. [10 ]
Cantini, F. [11 ]
Cutro, M. [2 ,3 ,4 ,5 ]
Mathieu, A.
Matucci-Cerinic, M. [12 ]
Pappone, N. [13 ]
Punzi, L. [14 ]
Scarpa, R. [15 ]
Mantovani, L. G. [15 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] San Carlo Hosp Potenza, Potenza, Italy
[3] Madonna Grazie Hosp, Potenza, Italy
[4] San Carlo Hosp Potenza, Matera, Italy
[5] Madonna Grazie Hosp, Matera, Italy
[6] Medtron Int Sarl, Tolochenaz, Switzerland
[7] Arcispedale S Maria Nuova, Reggio Emilia, Italy
[8] Univ Cagliari, Monserrato, Italy
[9] Univ Molise, Campobasso, Italy
[10] Univ Roma La Sapienza, I-00185 Rome, Italy
[11] Prato Hosp, Prato, Italy
[12] Univ Florence, Florence, Italy
[13] Fdn Maugeri IRCCS, Telese Terme, Italy
[14] Univ Padua, Padua, Italy
[15] Univ Naples Federico II, Naples, Italy
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1507
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A566 / A566
页数：1
相关论文
共 50 条
  • [1] Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: an extension of the Psoriatic Arthritis Cost Evaluation (PACE) study
    Olivieri, I.
    Cortesi, P. A.
    de Portu, S.
    Salvarani, C.
    Cauli, A.
    Lubrano, E.
    Spadaro, A.
    Cantini, F.
    Ciampichini, R.
    Cutro, M. S.
    Mathieu, A.
    Matucci-Cerinic, M.
    Punzi, L.
    Scarpa, R.
    Mantovani, L. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (01) : 68 - 75
  • [2] The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
    Olivieri, I.
    de Portu, S.
    Salvarani, C.
    Cauli, A.
    Lubrano, E.
    Spadaro, A.
    Cantini, F.
    Cutro, M. S.
    Mathieu, A.
    Matucci-Cerinic, M.
    Pappone, N.
    Punzi, L.
    Scarpa, R.
    Mantovani, L. G.
    RHEUMATOLOGY, 2008, 47 (11) : 1664 - 1670
  • [3] Tumor necrosis factor inhibitors in psoriatic arthritis
    Mantravadi, Santhi
    Ogdie, Alexis
    Kraft, Walter K.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 899 - 910
  • [4] TUMOR NECROSIS FACTOR INHIBITORS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, E.
    Eusebio, M.
    Avila-Ribeiro, P.
    Khmelinskii, N.
    Machado, A. R.
    Martins-Rocha, T.
    Bernardes, M.
    Santos-Faria, D.
    Leite Silva, J.
    Santos, H.
    Miguel, C.
    Carvalho, P.
    Costa, T.
    Teixeira, L.
    Meirinhos, T.
    Nero, P.
    Santos, M. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 731 - 732
  • [5] Tumor necrosis factor inhibitors continuationrates in patients with psoriatic arthritis: A Frenchretrospective monocentre study
    Rio, Simon
    Vincent, Fabien B.
    Michel, Murielle
    Cesini, Johann
    Marcelli, Christian
    JOINT BONE SPINE, 2015, 82 (05) : 377 - 378
  • [6] Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis
    Krueger, G
    Callis, K
    ARCHIVES OF DERMATOLOGY, 2004, 140 (02) : 218 - 225
  • [7] Discontinuation of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis and Psoriasis
    Wolfe, Sophia
    Cheng, Elizabeth
    Ganuthula, Kavya
    Fang, Meika
    Kerr, Gail
    Walsh, Jessica
    Chang, Elizabeth
    Raychaudhuri, Siba
    Brees, Kyle
    Dellavalle, Robert
    Reimold, Andreas
    Caplan, Liron
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3825 - 3827
  • [8] TUMOUR NECROSIS FACTOR INHIBITORS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, E.
    Eusebio, M.
    Avila-Ribeiro, P.
    Khmelinskii, N.
    Machado, A. R.
    Martins Rocha, T.
    Bernardes, M.
    Santos-Faria, D.
    Leite Silva, J.
    Santos, H.
    Miguel, C.
    Carvalho, P.
    Costa, T.
    Teixeira, L.
    Meirinhos, T.
    Nero, P.
    Santos, M. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1584 - 1585
  • [9] Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis
    Mori, Yu
    Kuwahara, Yoshiyuki
    Chiba, Shinpei
    Itoi, Eiji
    MODERN RHEUMATOLOGY, 2015, 25 (03) : 431 - 434
  • [10] DRUG SWITCHING IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR.
    Freites Nunez, D.
    Rodriguez Laguna, M.
    Martinez Prada, C.
    Fernandez, B.
    Lajas, C.
    Leon, L.
    Abasolo, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1788 - 1788
12345